Medical Advocates

HIV Infection/Disease
  Dyslipidemia
 
 
General Reports
Clinical Management




 


 

Adipose Tissue  Main Page   Main New/Newsworthy Home Page  

Last Update: March 17, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader.

General Reports

       

       Videos
 
 
Dyslipidemia and HIV
Heidi Crane, MD, MPH

        Journal Papers, Abstracts, and Commentaries

 
Influence of pharmacotherapy complexity on compliance with the therapeutic objectives for HIV+ patients on antiretroviral treatment concomitant with therapy for dyslipidemia. INCOFAR Project.
Jiménez Galán R, Montes Escalante IM, Morillo Verdugo R.

Farm Hosp
. 2016 Mar 1;40(n02):90-101.
Abstract

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L, Martínez E,  et al

AIDS
. 2012 Dec 19..
Abstract

The distribution of Apolipoprotein E gene polymorphism and their influences in dyslipidemias in HIV-1 infections.
Suwalak T, Srisawasdi P, Puangpetch A, et al
Jpn J Infect Dis. 2014 Nov 25.
Abstract

FULL-TEXT ARTICLE
Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor.
Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI,  et al
Sex Med. 2014 Apr;2(1):24-30
Paper

FULL-TEXT ARTICLE
Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
Abebe M, Kinde S, Belay G,  et al
BMC Res Notes. 2014 Jun 21;7:380. 
Paper

Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients.
Myerson M, Poltavskiy E, Armstrong EJ,
J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):370-7.
Abstract

FULL-TEXT ARTICLE
Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.
Lazzaretti RK, Gasparotto AS, Sassi MG, et al
ScientificWorldJournal. 2013 Sep 26;2013:608415
Paper

FULL-TEXT ARTICLE
Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S, Sani MU, Okeahialam BN.
Ann Afr Med. 2013 Jan-Mar;12(1):24-8
Paper

Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011.
Tripathi A, Jerrell JM, Liese AD,  et al
Metab Syndr Relat Disord. 2013 Dec;11(6):417-26
Abstract

FULL-TEXT PDF ARTICLE
Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study.
Tadewos A, Addis Z, Ambachew H, Banerjee S.
AIDS Res Ther. 2012 Oct 25;9(1):31.
Paper

FULL-TEXT ARTICLE
Dyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study.
Pefura Yone EW, Kengne AP,
Ashuntantang G,  et al
BMJ Open
. 2012 Aug 8;2(
Paper

FULL-TEXT ARTICLE
HIV and HAART-Associated Dyslipidemia.
Feeney ER, Mallon PW.
Open Cardiovasc Med J. 2011;5:49-63.
Paper

The Effect of polymorphisms in candidate genes on the Long-Term Risk of Lipodystrophy
and Dyslipidemia in HIV-infected Caucasians Starting Antiretroviral Therapy.
Marzocchetti A, Schwarz J, DI Giambenedetto S,   et al

AIDS Res Hum Retroviruses
. 2011 May 20.
Abstract

FULL-TEXT ARTICLE
Dyslipidemia in AIDS patients on highly active antiretroviral therapy.
Nery MW, Martelli CM, Turchi MD.

Braz J Infect Dis
. 2011 Apr;15(2):151-5.
Paper

Dyslipidemia related to antiretroviral therapy.
EstradaV, Portilla J.

AIDS Rev
. 2011 Jan-Mar;13(1):49-56.
Abstract

 

Clinical Management

       

        Journal Papers, Abstracts, and Commentaries
 
 
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.
Calza L, Colangeli V, Manfredi R, et al 
J Antimicrob Chemother. 2016 Feb 3.
Abstract

Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy.
Grandi AM, Nicolini E, Rizzi L, et al

J Int AIDS Soc
. 2014 Aug 21;17:19004. .
Abstract

Management of dyslipidemia in patients with human immunodeficiency virus.
Shalit P.
Rev Cardiovasc Med. 2014;15 Suppl 1:S38-46.
Abstract

Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
Pedersen KK, Pedersen M, Trøseid M,  et al
J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):425-33
Abstract

Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT.
Postgrad Med. 2012 Jan;124(1):31-40..
Abstract

Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug
leflunomide in a PPAR-γ-dependent manner.
Mencarelli A, Francisci D, Renga B,  et al
Antivir Ther
. 2012 Jan 25.

Abstract

FULL-TEXT PDF ARTICLE
Dyslipidemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the
Spanish VACH cohort.

Estrada V, Geijo P, Fuentes-Ferrer M, et al  
BMC Womens Healt
h
. 2011 Aug 4;11(1):36

Paper

Combination of Niacin and Fenofibrate with Lifestyle Changes Improves Dyslipidemia
and Hypoadiponectinemia in HIV Patients on Antiretroviral Therapy: Results of
"Heart Positive," a Randomized, Controlled Trial.

Balasubramanyam A, Coraza I, Smith EO,  et al
J Clin Endocrinol Metab
. 2011 May 11
Abstract

Dyslipidemia and lipid management in HIV-infected patients.
Lo J.

Curr Opin Endocrinol Diabetes Obes
. 2011 Feb 3
Abstract

Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
Singh S, Willig JH, Mugavero MJ,M., et al
Clin Infect Dis. 2010 Dec 28.
Abstract

Treatment of dyslipidemia in HIV-infected patients.
Sekhar RV, Balasubramanyam A.

Expert Opin Pharmacother
. 2010 May 20
Abstract                                                   

 

   

                    


Adipose Tissue  Main Page   Main New/Newsworthy Home Page  

Dyslipidemia